Last edition
News about "Piramal Pharma"
Piramal Pharma Solutions leveraged its CDMO expertise to help George Medicines develop WIDAPLIK, the first and only FDA-approved triple combination therapy for hypertension, combining telmisartan, amlodipine, and indapamide to effectively lower blood pressure.
Piramal Pharma | 01/09/2025 | By Mrinmoy Dey
Piramal Pharma to Operate its Digwal Facility on Biomass Briquettes to Promote Sustainability
This achievement marks a substantial step toward Piramal's sustainability goal to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 42 percent by 2030.
Piramal Pharma | 16/01/2025 | By Aishwarya | 335
Piramal Pharma Gets SBTi Approval for its GHG Emission Reduction Targets
Piramal Pharma Ltd. has committed to reduce absolute scope 1 and 2 GHG emissions 42 percent by FY2030 from a FY2022 base year.
Piramal Pharma | 17/09/2024 | By Aishwarya | 352
Piramal Pharma Gets EIR from US FDA for Bethlehem Plant
The EIR report signifies the closure of the inspection.
Piramal Pharma | 10/11/2023 | By Manvi | 757
Piramal Pharma gets EIR from US FDA for Sellersville, USA facility
The inspection has now been successfully closed by the US FDA
Piramal Pharma | 19/04/2023 | By Sudeep Soparkar | 745
Piramal Pharma gets EIR for Lexington, Kentucky facility
The inspection has been successfully completed<br />
Piramal Pharma | 20/02/2023 | By Sudeep Soparkar | 595
Piramal Pharma's Lexington facility gets six observations from US FDA
The observations were classified under VAI (Voluntary Action Indicated) and do not relate to data integrity<br />
Piramal Pharma | 17/01/2023 | By Sudeep Soparkar | 327
Piramal Pharma gets zero observations from US FDA for Riverview, Michigan facility
The inspection was completed successfully with Zero Form - 483 observations
Piramal Pharma | 11/11/2022 | By Sudeep Soparkar | 813
Piramal Pharma Solutions opens API plant in Ontario
The new plant, built as part of a CAD 30 million capital investment in the Aurora site, features more than ten thousand square feet of new manufacturing space
Piramal Pharma | 12/07/2022 | By Sudeep Soparkar | 791
Piramal Pharma inducts Peter Stevenson, Nathalie Leitch and Sridhar Gorthi to its board
The appointments will add to the well-diversified experience that currently exists on the PPL board
Piramal Pharma | 07/07/2022 | By Sudeep Soparkar | 784
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy